Shannon covers pharmaceutical quality, manufacturing, and regulatory issues for Informa. She is also interested in environmental issues and covers topics such as streamlining the manufacturing process to improve sustainability. She started her career as a writer and editor at the US National Cancer Institute. After several years of freelancing for healthcare and environmental outlets, she received an MA in Science Writing from Johns Hopkins University and started at Informa.
Hailing from Oahu, Hawaii, she enjoys travel and is also an avid reader and practitioner of yoga. She speaks Spanish and elementary German.
Latest From Shannon Brown
Extension will add training materials with goal of reducing quality defects and recalls. Revision process will also address shortage indicators related to production failures in an attempt to head off drug shortages.
Product sampling and remote records requests accounted for most import alerts and drug GMP warning letters over the past year – and may play key role post-pandemic.
More testing expected after B. cepacia contamination of OTC liquid drug products, including for Rx drug products.
Agency will provide guidance in wake of recent outbreaks of Burkholderia cepacia in non-sterile, water-based drug products.
After decades without an approval pathway for excipients, FDA pilot program paves the way for innovation.